Marc Nash Biography and Net Worth

SVP of Outset Medical

Marc Nash joined Outset in December 2019, serving as Vice President of Manufacturing from 2020 – 2022 before being appointed as SVP, Operations and R&D in 2023. In his role at Outset, he has developed and deployed a near-shore manufacturing model which included the design and construction of a globally recognized state-of-the-art 4IR digital manufacturing facility. Marc brings 15+ years of medical device operational management in which he led organizations in 4 countries through the phases of startup, hypergrowth and profitability. Prior to Outset, Marc served as the Director of Operations at Siemens Healthineers and Alere Inc. In which he was responsible for the end-to-end manufacturing operations of point of care diagnostics products and platforms.

Marc holds an MBA from the University of Haifa, Israel and a Bachelor of Science in Bioengineering, from Union College, New York.

What is Marc Nash's net worth?: The estimated net worth of Marc Nash is at least $227.82 thousand as of November 17th, 2025. Nash owns 48,268 shares of Outset Medical stock worth more than $227,825 as of December 5th. This net worth estimate does not reflect any other assets that Nash may own. Learn More about Marc Nash's net worth.
How old is Marc Nash?: Nash is currently 35 years old. There are 5 older executives and no younger executives at Outset Medical. The oldest executive at Outset Medical is Mr. Mark Gordon M.S., Chief Regulatory & Quality Officer, who is 67 years old. Learn More on Marc Nash's age.
How do I contact Marc Nash?: The corporate mailing address for Nash and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Marc Nash's contact information.
Has Marc Nash been buying or selling shares of Outset Medical?: Over the course of the past ninety days, Marc Nash has sold $1,136.20 in Outset Medical stock. Most recently, Marc Nash sold 247 shares of the business's stock in a transaction on Monday, November 17th. The shares were sold at an average price of $4.60, for a transaction totalling $1,136.20. Following the completion of the sale, the executive vice president now directly owns 48,268 shares of the company's stock, valued at $222,032.80. Learn More on Marc Nash's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Marc Nash (SVP), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 23 times. They sold a total of 24,777 shares worth more than $297,113.91. The most recent insider tranaction occured on December, 1st when Director Karen Drexler sold 1,548 shares worth more than $6,764.76. Insiders at Outset Medical own 2.4% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 12/1/2025.

Marc Nash Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/17/2025	Sell	247	$4.60	$1,136.20	48,268
5/15/2025	Sell	252	$17.82	$4,490.64	13,465
2/18/2025	Sell	280	$13.50	$3,780.00	13,384
1/21/2025	Sell	1,548	$12.00	$18,576.00	13,664
1/13/2025	Sell	1,000	$12.15	$12,150.00	14,819
1/7/2025	Sell	48	$19.35	$928.80	15,820
11/15/2024	Sell	91	$12.00	$1,092.00	15,868
8/15/2024	Sell	86	$12.60	$1,083.60	15,959
7/24/2024	Sell	48	$60.30	$2,894.40	16,046
5/16/2024	Sell	73	$52.95	$3,865.35	16,094
3/15/2024	Sell	159	$31.95	$5,080.05	16,167
2/15/2024	Sell	41	$53.55	$2,195.55	16,206
1/16/2024	Sell	45	$6,435.00	$289,575.00	16,247

Marc Nash Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $4.72

$4.16

$4.79

50 Day Range

MA: $10.54

$4.05

$15.81

2 Week Range

Now: $4.72

$4.00

$25.35

Volume

627,131 shs

Average Volume

814,952 shs

Market Capitalization

$85.67 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.03

Marc Nash Biography and Net Worth

What is Marc Nash's net worth?

How old is Marc Nash?

How do I contact Marc Nash?

Has Marc Nash been buying or selling shares of Outset Medical?

Who are Outset Medical's active insiders?

Are insiders buying or selling shares of Outset Medical?